Bethanechol: Clinical Trials

7 trials of Bethanechol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 terminated, 1 unknown. 2 Phase 1, 2 Phase 2, 1 Early Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Recruiting 1, Terminated 1
Early Phase 11Completed 1
Phase 41Completed 1

Follow Bethanechol: new trials by email Literature Review of Bethanechol trials Research Report on Bethanechol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Bethanechol on Tracheobronchomalacia
Bethanechol - Tracheobronchomalacia
UnknownArkansas Children's Hospital Research Institute202022-08-112024-01-30
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
Bethanechol, Gemcitabine, nab-paclitaxel - Pancreas Cancer
Phase 2RecruitingSusan E. Bates372022-02-012025-06-05
Bethanechol Prior to Pancreatic Surgery
Bethanechol - Pancreas Cancer
Early Phase 1CompletedColumbia University172018-04-082025-06-05
Effectiveness of Bethanechol Chloride and Early Bladder Training for Prevention of Bladder Dysfunction After Radical Hysterectomy in Cervical Cancer Stage IB - IIA
bethanechol chloride, early bladder training, early bladder training and bethanechol chloride - Bladder Dysfunction
Phase 4CompletedDepartment of Medical Services Ministry of Public Health of Thailand562016-10-012020-10-23
Bethanechol for Eosinophilic Esophagitis
Bethanechol - Eosinophilic Esophagitis (EoE)
Phase 2TerminatedUniversity of Iowa22014-02-012016-04-22
The Effects of Bethanechol on Glucose Homeostasis
Placebo, Bethanechol (25 mg), Bethanechol (50 mg) - Type 2 Diabetes Mellitus
Phase 1CompletedWashington University School of Medicine502011-08-152018-05-08
Topical Bethanechol for Improvement of Esophageal Dysmotility
Bethanechol - Esophageal Dysmotility
Phase 1CompletedAugusta University52009-11-012015-01-29

Conditions studied

Adenocarcinoma (2)  ·  Pancreatic Neoplasms (2)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Eosinophilic Esophagitis (1)  ·  Esophageal Motility Disorders (1)  ·  Tracheobronchomalacia (1)

Sponsors

Arkansas Children's Hospital Research Institute (1)  ·  Augusta University (1)  ·  Columbia University (1)  ·  Department of Medical Services Ministry of Public Health of Thailand (1)  ·  Susan E. Bates (1)  ·  University of Iowa (1)  ·  Washington University School of Medicine (1)

Countries

United States (6)  ·  Thailand (1)

Top investigators

Susan E Bates, MD (2)  ·  Burton M Wice, PhD (1)  ·  Charles P Pugh, MD (1)  ·  Dominic Reeds, MD (1)  ·  Gregory N Postma, MD (1)  ·  Yehudith Assouline-Dayan, MD (1)

Results publications

PMID 27304975

NIH funding

R01DK088126 (1)